Relmada Therapeutics, Inc. RLMD Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s earnings yield?
- Relmada Therapeutics, Inc. (RLMD) reported earnings yield of -8.1% in Q1 2026.
- How has Relmada Therapeutics, Inc.'s earnings yield changed year-over-year?
- Relmada Therapeutics, Inc.'s earnings yield increased by 99.0% year-over-year, from -844.8% to -8.1%.
- What is the long-term trend for Relmada Therapeutics, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s earnings yield has grown at a 19.4% compound annual growth rate (CAGR), from -6.7% to -16.2%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.